Recro Pharma, Inc. (REPH) earnings
Quarterly and annual REPH reports and results, each read against the price at its own news timestamp. Back to the REPH overview →
No REPH earnings events in the measured window.
Nothing matched in the current window — the REPH overview has every event we measure for this name.
Get an email when REPH moves on news →Keep exploring
More REPH: analyst actions → · SEC filings → · REPH overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | 967 | +0.12% | 56% |
| QuidelOrtho Corporation (QDEL) | 965 | +0.02% | 50% |
| Athenex, Inc. (ATNX) | 964 | -0.43% | 41% |
| United Therapeutics Corporation (UTHR) | 964 | +0.03% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.